Literature DB >> 10037383

Distribution of post-void residual urine volume in randomly selected men.

C Kolman1, C J Girman, S J Jacobsen, M M Lieber.   

Abstract

PURPOSE: We describe the distribution of post-void residual urine volume and its relationship to other urological measurements in a random sample of men.
MATERIALS AND METHODS: Post-void residual was measured by transabdominal ultrasonography after voiding and prostate volume was measured by transrectal ultrasonography in 477 randomly selected community dwelling white men as part of a baseline urological evaluation. Symptoms were characterized with the American Urological Association symptom index. Acute urinary retention cases with catheterization in the subsequent 3 to 4 years were identified through chart review.
RESULTS: The distribution of post-void residual was highly skewed with a median of 9.5 ml., and 25th and 75th percentiles equal to 2.5 and 35.4, respectively. There was a significant correlation of post-void residual with prostate volume (rs = 0.24, p <0.001). The odds of post-void residual greater than 50 ml. were 2.5 times greater for men with prostate volume greater than 30 ml. than those with smaller prostates. In regression analyses post-void residual did not appear to be associated with the American Urological Association symptom index, age or peak urinary flow rate. Men with enlarged prostate volume or post-void residual greater than 50 ml. at baseline were about 3 times as likely to have subsequent acute urinary retention with catheterization during 3 to 4 years of followup.
CONCLUSIONS: These results suggest little variation in the distribution of post-void residual urine volume across age groups or levels of urinary symptoms and peak urinary flow rate. However, a somewhat stronger relationship was found between residual urine and prostate volume.

Entities:  

Mesh:

Year:  1999        PMID: 10037383

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  22 in total

Review 1.  The use of baseline clinical measures to predict those at risk for progression of benign prostatic hyperplasia.

Authors:  Edward D Kim
Journal:  Curr Urol Rep       Date:  2004-08       Impact factor: 3.092

2.  Cranberry fruit powder (Flowens™) improves lower urinary tract symptoms in men: a double-blind, randomized, placebo-controlled study.

Authors:  Ales Vidlar; Vladimir Student; Jitka Vostalova; Emilie Fromentin; Marc Roller; Vilím Simanek; Vladimir Student
Journal:  World J Urol       Date:  2015-06-07       Impact factor: 4.226

3.  Experience with uroflowmetry in evaluation of lower urinary tract symptoms in patients with benign prostatic hyperplasia.

Authors:  Sanjeev Singla; Ramneesh Garg; Ankit Singla; Sandeep Sharma; Jasdeep Singh; Pulkit Sethi
Journal:  J Clin Diagn Res       Date:  2014-04-15

4.  Effect of Longbishu capsule () plus doxazosin on benign prostatic hyperplasia: a randomized controlled trial.

Authors:  Chun-Sheng Song; Jun Guo; De-Gui Chang; Lei Chen; Rui Zhang; Jia-You Zhao; Fu Wang; Qiang Zhang
Journal:  Chin J Integr Med       Date:  2014-06-18       Impact factor: 1.978

Review 5.  Clinical value of prostate segmentation and volume determination on MRI in benign prostatic hyperplasia.

Authors:  Brian Garvey; Barış Türkbey; Hong Truong; Marcelino Bernardo; Senthil Periaswamy; Peter L Choyke
Journal:  Diagn Interv Radiol       Date:  2014 May-Jun       Impact factor: 2.630

6.  Clinical evaluation of benign prostatic hyperplasia.

Authors:  Kevin T McVary
Journal:  Rev Urol       Date:  2003

7.  Clinical evaluation of benign prostatic hyperplasia.

Authors:  Kevin T McVary
Journal:  Rev Urol       Date:  2003

Review 8.  How do urodynamics findings influence the treatment of the typical patient with overactive bladder?

Authors:  Matthew P Rutman; Doh Yoon Cha; Jerry G Blaivas
Journal:  Curr Urol Rep       Date:  2012-10       Impact factor: 3.092

Review 9.  Acute kidney injury in the elderly.

Authors:  Khaled Abdel-Kader; Paul M Palevsky
Journal:  Clin Geriatr Med       Date:  2009-08       Impact factor: 3.076

10.  Algorithms for the management of overactive bladder.

Authors:  Richard T Kershen
Journal:  Curr Urol Rep       Date:  2009-09       Impact factor: 3.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.